Pregnancy outcomes in women with certain autoimmune conditions
Treatments studied
Part of Skin clinical trials.
This study looks at the typical pregnancy course and outcomes for women with APS or UCTD, two autoimmune-related conditions. It also checks how these conditions and treatments may affect pregnancy, so doctors can better plan care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 20 to 45.
- You have been diagnosed with APS (antiphospholipid syndrome) or UCTD (an “unclassified” connective tissue disease) based on the study’s required antibody and symptom findings.
- You must have signs and/or symptoms that fit an autoimmune connective tissue disease (for UCTD) but not meet the full criteria for a specific defined connective tissue disease.
- You can join voluntarily, take the planned medications, attend follow-up visits, and sign consent.
- You do NOT have certain conditions that can strongly affect pregnancy (like known chromosome problems, specific hormone problems, major uterine problems, or serious heart/liver/kidney/blood/endocrine disease).
- You do NOT have an active infection (like HIV, syphilis, tuberculosis, VZV, HPV) and you are not allergic to prednisone, hydroxychloroquine, low-molecular-weight heparin, or aspirin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study looks at a treatment plan for people with systemic lupus (SLE) during pregnancy and tracks health outcomes for mother and baby. It may help doctors learn how to manage SLE safely in pregnancy and what results to expect.
This study is a pregnancy and health registry for women with autoimmune (immune system) conditions who are trying to become pregnant or are already pregnant. It helps researchers better understand pregnancy outcomes and health needs in autoimmune disease.
This study looks at women who used a topical eczema cream called ruxolitinib (Opzelura) or steroid creams during pregnancy. The goal is to compare pregnancy outcomes and baby health up to one year after birth.
This study looks for factors that may predict how pregnancy turns out in people with lupus (SLE) and/or antiphospholipid syndrome (APS). It may help doctors better understand what to monitor in early pregnancy to support healthier outcomes.
This study is looking at pregnancy outcomes in people who are pregnant and either have antiphospholipid antibody syndrome (APS) or do not have APS but do have prior full-term pregnancies. It may help doctors understand risks and how to manage pregnancies in these groups.
This study looks at a specific antibody (anti-C1q) in pregnant women, including those with normal pregnancies, preeclampsia (high blood pressure and protein in urine after 20 weeks), or autoimmune conditions like lupus or antiphospholipid syndrome. The goal is to understand how this antibody might affect pregnancy and help guide care.
Hear when a new Connective Tissue Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.